Innovating.works Conecta tu I+D

Mostrando 1 al 20 de 36 resultados

DEFINITIVE: Diagnostic HER2DX-guided treatment for patients with early-stage HER2-positive breast cancer MEDICAL RESEARCH INFRASTRUCTURE DEVELOPMENT AND HEALTH SERVICES FUND BY THE SHEBA MEDICAL CENTER participó en un HORIZON EUROPE: HORIZON-MISS-2023-CANCER-01 HER2+ breast cancer affects around 390.000 women annually worldwide (i.e. 3 patients every 4 minutes). Over the last decade, polychemotherap...
2023-12-11 - 2028-11-30 | Financiado

COMBINE-CT: Combining CT diagnostic data and interventional approaches for futureproof cardiology care MEDICAL RESEARCH INFRASTRUCTURE DEVELOPMENT AND HEALTH SERVICES FUND BY THE SHEBA MEDICAL CENTER participó en un HORIZON EUROPE: HORIZON-JU-IHI-2022-03-single-stage "Coronary artery disease (CAD) is caused by the pathological process in which fat, cholesterol and calcium accumulate on the arterial wall....
2023-10-27 - 2027-10-31 | Financiado

PragmaTIL: Pragmatic approach to Adoptive Cell Therapy (ACT) using Tumor Infiltrating Lymphocytes (TIL) in sele... MEDICAL RESEARCH INFRASTRUCTURE DEVELOPMENT AND HEALTH SERVICES FUND BY THE SHEBA MEDICAL CENTER participó en un HORIZON EUROPE: HORIZON-MISS-2022-CANCER-01 The PragmaTIL trial aims to optimize treatment of cancer patients with Tumour-Infiltrating Lymphocytes Adoptive Cell Therapy (TIL-ACT) and s...
2023-04-28 - 2028-03-31 | Financiado

Bootstrap: Boosting Societal Adaptation and Mental Health in a Rapidly Digitalizing Post Pandemic Europe MEDICAL RESEARCH INFRASTRUCTURE DEVELOPMENT AND HEALTH SERVICES FUND BY THE SHEBA MEDICAL CENTER participó en un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-01-two-stage BACKGROUND: Adolescents are at particularly high risk for digital technology overuse, including in response to the COVID pandemic, and are t...
2023-04-21 - 2028-06-30 | Financiado

ThermoBreast: An innovative non-contact and harmless screening modality set to change the course of breast cancer... MEDICAL RESEARCH INFRASTRUCTURE DEVELOPMENT AND HEALTH SERVICES FUND BY THE SHEBA MEDICAL CENTER participó en un HORIZON EUROPE: HORIZON-MISS-2021-CANCER-02 Female breast cancer is the most diagnosed cancer worldwide. In 2020, the International Agency for Research on Cancer estimated more than 2....
2022-11-28 - 2026-12-31 | Financiado

GeneCKD: Deciphering the genetic basis of chronic kidney disease towards prevention and personalized therapy MEDICAL RESEARCH INFRASTRUCTURE DEVELOPMENT AND HEALTH SERVICES FUND BY THE SHEBA MEDICAL CENTER tramitó un HORIZON EUROPE: ERC-2021-STG Chronic Kidney Disease (CKD) is a public health challenge affecting millions globally. Patients have increased risks of mortality, morbidity...
2022-06-01 - 2027-06-30 | Financiado

CINDERELLA: Clinical Validation of an AI-based approach to improve the shared decision-making process and outcom... MEDICAL RESEARCH INFRASTRUCTURE DEVELOPMENT AND HEALTH SERVICES FUND BY THE SHEBA MEDICAL CENTER participó en un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 Breast cancer is the most commonly diagnosed cancer, with an estimated 2.3 million new cases per year globally. Approximately 90% of these...
2022-05-23 - 2026-05-31 | Financiado

VirA: Reducing networking gaps between R ga Stradi University RSU and internationally leading counte... MEDICAL RESEARCH INFRASTRUCTURE DEVELOPMENT AND HEALTH SERVICES FUND BY THE SHEBA MEDICAL CENTER participó en un H2020: H2020-WIDESPREAD-2018-2020 The specific challenge of VirA Twinning project is to enhance networking activities between the Riga Stradins University (RSU) located in La...
2020-06-29 - 2023-11-30 | Financiado

EJP RD: European Joint Programme on Rare Diseases MEDICAL RESEARCH INFRASTRUCTURE DEVELOPMENT AND HEALTH SERVICES FUND BY THE SHEBA MEDICAL CENTER participó en un H2020: H2020-SC1-BHC-2018-2020 As recognized by the Council Recommendation 2009/C 151/02, rare diseases (RD) are a prime example of a research area that can strongly profi...
2018-12-13 - 2024-08-31 | Financiado

cureCD: Function of long non coding RNA in Crohn Disease Ulcer Pathogenesis MEDICAL RESEARCH INFRASTRUCTURE DEVELOPMENT AND HEALTH SERVICES FUND BY THE SHEBA MEDICAL CENTER tramitó un H2020: ERC-2017-STG The Inflammatory Bowel Diseases (IBD), Crohn’s Disease (CD) and Ulcerative Colitis (UC) are chronic/relapsing disorders that affect over six...
2018-03-28 - 2024-10-31 | Financiado

RECOMB: Stem cell based gene therapy for recombination deficient SCID RECOMB MEDICAL RESEARCH INFRASTRUCTURE DEVELOPMENT AND HEALTH SERVICES FUND BY THE SHEBA MEDICAL CENTER participó en un H2020: H2020-SC1-2016-2017 Gene therapy for rare inherited immune disorders has become a clinical reality. Especially for SCID, two major types of SCID (ADA-SCID, X-SC...
2017-11-21 - 2024-12-31 | Financiado

m1ARNA: Transcriptomic m1A a new key player in the epitranscriptome arena MEDICAL RESEARCH INFRASTRUCTURE DEVELOPMENT AND HEALTH SERVICES FUND BY THE SHEBA MEDICAL CENTER tramitó un H2020: ERC-2016-ADG Reversible epigenetic modifications regulate gene expression to define cell fate and response to environmental stimuli. Gene expression tun...
2017-06-12 - 2022-06-30 | Financiado

IEDAT: Intra Erythrocyte Dexamethasone in the treatment of Ataxia Telangiectasia MEDICAL RESEARCH INFRASTRUCTURE DEVELOPMENT AND HEALTH SERVICES FUND BY THE SHEBA MEDICAL CENTER participó en un H2020: H2020-PHC-2014-2015 The main objective of the project is to provide a treatment of the neurological symptoms of patients with Ataxia Telangiectasia (AT), a rare...
2015-12-09 - 2021-08-31 | Financiado

MAMEM: Multimedia Authoring and Management using your Eyes and Mind MEDICAL RESEARCH INFRASTRUCTURE DEVELOPMENT AND HEALTH SERVICES FUND BY THE SHEBA MEDICAL CENTER participó en un H2020: H2020-ICT-2014 Loss of the voluntary muscular control while preserving cognitive functions is a common symptom of neuromuscular disorders leading to a vari...
2015-04-20 - 2018-07-31 | Financiado

BIOCYCLE: BIOlogical therapy CYCLEs towards tailored needs driven safer and cost effective management of Cro... MEDICAL RESEARCH INFRASTRUCTURE DEVELOPMENT AND HEALTH SERVICES FUND BY THE SHEBA MEDICAL CENTER participó en un H2020: H2020-PHC-2014-2015 "The BIOCYCLE Project proposes to test and critically assess the benefits and risks of an innovative regimen for improving the treatment of...
2015-03-31 - 2022-12-31 | Financiado

PACE: Perception and Action in Complex Environments MEDICAL RESEARCH INFRASTRUCTURE DEVELOPMENT AND HEALTH SERVICES FUND BY THE SHEBA MEDICAL CENTER participó en un H2020: H2020-MSCA-ITN-2014 The PACE research and training programme sits at the interface between basic science, technology and clinics, in order to unveil how humans...
2015-02-17 - 2019-03-31 | Financiado

NEVUS CLASSIFICATION: Classification and longitudinal follow up of common melanocytic nevi with in vivo reflectance confoc... MEDICAL RESEARCH INFRASTRUCTURE DEVELOPMENT AND HEALTH SERVICES FUND BY THE SHEBA MEDICAL CENTER tramitó un FP7: Nevi are the strongest risk markers of melanoma. Common nevi are still regarded clinically as a single entity, despite data suggesting that...
Financiado

Sheba Research Fund